Literature DB >> 14659745

Crystal structure of the catalytic domain of human ADAM33.

Peter Orth1, Paul Reichert, Wenyan Wang, Winifred W Prosise, Taisa Yarosh-Tomaine, Gerald Hammond, Richard N Ingram, Li Xiao, Urooj A Mirza, Jun Zou, Corey Strickland, S Shane Taremi, Hung V Le, Vincent Madison.   

Abstract

Adam33 is a putative asthma susceptibility gene encoding for a membrane-anchored metalloprotease belonging to the ADAM family. The ADAMs (a disintegrin and metalloprotease) are a family of glycoproteins implicated in cell-cell interactions, cell fusion, and cell signaling. We have determined the crystal structure of the Adam33 catalytic domain in complex with the inhibitor marimastat and the inhibitor-free form. The structures reveal the polypeptide fold and active site environment resembling that of other metalloproteases. The substrate-binding site contains unique features that allow the structure-based design of specific inhibitors of this enzyme.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14659745     DOI: 10.1016/j.jmb.2003.10.037

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  24 in total

1.  Structure of human ADAM-8 catalytic domain complexed with batimastat.

Authors:  Troii Hall; Huey Sheng Shieh; Jacqueline E Day; Nicole Caspers; Jill E Chrencik; Jennifer M Williams; Lyle E Pegg; Adele M Pauley; Andrea F Moon; Joseph M Krahn; David H Fischer; James R Kiefer; Alfredo G Tomasselli; Marc D Zack
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2012-05-22

2.  ADAM33 is not essential for growth and development and does not modulate allergic asthma in mice.

Authors:  Chun Chen; Xiaozhu Huang; Dean Sheppard
Journal:  Mol Cell Biol       Date:  2006-09       Impact factor: 4.272

3.  Cooperation of the metalloprotease, disintegrin, and cysteine-rich domains of ADAM12 during inhibition of myogenic differentiation.

Authors:  Haiqing Yi; Joanna Gruszczynska-Biegala; Denise Wood; Zhefeng Zhao; Anna Zolkiewska
Journal:  J Biol Chem       Date:  2005-04-23       Impact factor: 5.157

4.  Crystal structures of VAP1 reveal ADAMs' MDC domain architecture and its unique C-shaped scaffold.

Authors:  Soichi Takeda; Tomoko Igarashi; Hidezo Mori; Satohiko Araki
Journal:  EMBO J       Date:  2006-05-11       Impact factor: 11.598

5.  Extracellular cleavage of cadherin-11 by ADAM metalloproteases is essential for Xenopus cranial neural crest cell migration.

Authors:  Catherine McCusker; Hélène Cousin; Russell Neuner; Dominique Alfandari
Journal:  Mol Biol Cell       Date:  2008-10-22       Impact factor: 4.138

Review 6.  The role of the epithelium in airway remodeling in asthma.

Authors:  Donna E Davies
Journal:  Proc Am Thorac Soc       Date:  2009-12

7.  Structural characterization of the ectodomain of a disintegrin and metalloproteinase-22 (ADAM22), a neural adhesion receptor instead of metalloproteinase: insights on ADAM function.

Authors:  Heli Liu; Ann H R Shim; Xiaolin He
Journal:  J Biol Chem       Date:  2009-08-18       Impact factor: 5.157

Review 8.  Targeting Metalloenzymes for Therapeutic Intervention.

Authors:  Allie Y Chen; Rebecca N Adamek; Benjamin L Dick; Cy V Credille; Christine N Morrison; Seth M Cohen
Journal:  Chem Rev       Date:  2018-09-07       Impact factor: 60.622

9.  Savior or not: ADAM17 inhibitors overcome radiotherapy-resistance in non-small cell lung cancer.

Authors:  Katsuaki Ieguchi; Yoshiro Maru
Journal:  J Thorac Dis       Date:  2016-08       Impact factor: 2.895

Review 10.  ADAM proteases: ligand processing and modulation of the Notch pathway.

Authors:  A Zolkiewska
Journal:  Cell Mol Life Sci       Date:  2008-07       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.